ALDH1A3 was reported to be expressed in CTCs having acquired CSC and mesenchymal features46 and is commonly associated with chemoresistance and worse survival in many cancers including mBC, though only at baseline and no longer when monitored during chemotherapy.47, 48, 49. This evidence concerns the gene ALDH1A3 and cancer.